ABOUT PHARMA EXCIPIENTS

“The existing condition has uncovered some structural weaknesses during the EU’s medicines source chain and a large dependence on non-EU nations around the world for active pharmaceutical ingredients,” Kyriakides mentioned. She advised that supply chain problems be tackled in an EU pharmaceutical technique envisioned to generally be introduce